-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, E1gCthlLyJbdiNx1xzmK2g8lbK9EpXNso4B6PA7sR5fLzPCkgWA10YBxNNi9V5Pe Tj+VurMr9a1rAcgryOtyiA== 0000898430-97-005209.txt : 19971209 0000898430-97-005209.hdr.sgml : 19971209 ACCESSION NUMBER: 0000898430-97-005209 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 19971208 SROS: NASD GROUP MEMBERS: BIOTECHNOLOGY VALUE FUND L P ET AL GROUP MEMBERS: BVF PARTNERS, L.P. GROUP MEMBERS: BVF, INC. SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: ARRIS PHARMACEUTICAL CORP/DE/ CENTRAL INDEX KEY: 0000913056 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222969941 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-44967 FILM NUMBER: 97734102 BUSINESS ADDRESS: STREET 1: 180 KIMBALL WAY CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 4157378600 MAIL ADDRESS: STREET 1: 385 OYSTER POINT BLVD STREET 2: SUITE 3 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: BIOTECHNOLOGY VALUE FUND L P ET AL CENTRAL INDEX KEY: 0000918923 STANDARD INDUSTRIAL CLASSIFICATION: INVESTMENT ADVICE [6282] IRS NUMBER: 363924731 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: 39TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 BUSINESS PHONE: 415-288-2395 MAIL ADDRESS: STREET 1: ONE SANSOME STREET STREET 2: 39TH FLOOR CITY: SAN FRANCISCO STATE: CA ZIP: 94104 SC 13D/A 1 SCHEDULE 13D SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 -------------------- SCHEDULE 13D (RULE 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO 13D- 1(A) AND AMENDMENTS THERETO FILED PURSUANT TO 13D-2(A) (AMENDMENT NO. 1)/1/ ARRIS PHARMACEUTICAL CORPORATION -------------------------------- (Name of Issuer) Common Stock ------------ (Title of Class of Securities) 04269 W 107 ----------- (CUSIP Number) Hope Flack BVF Partners L.P. 333 West Wacker Drive, Suite 1600 Chicago, Illinois 60606 (312) 263-7777 -------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) December 4, 1997 ---------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check the following box [_]. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. (Continued on following pages) (Page 1 of 10 Pages) - -------------------- /1/ The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). - ----------------------- --------------------- CUSIP NO. 04269 W 107 SCHEDULE 13D PAGE 2 OF 10 PAGES - ----------------------- --------------------- - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON Biotechnology Value Fund, L.P. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [X] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ SOURCE OF FUNDS* 4 WC - ------------------------------------------------------------------------------ CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO 5 ITEMS 2(d) or 2(e) [_] - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 6 Delaware - ------------------------------------------------------------------------------ SOLE VOTING POWER 7 NUMBER OF 0 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 8 398,621 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 9 REPORTING 0 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 10 398,621 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 11 398,621 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* 12 [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 13 2.6% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 14 PN - ------------------------------------------------------------------------------ *SEE INSTRUCTIONS BEFORE FILLING OUT! - ----------------------- --------------------- CUSIP NO. 04269 W 107 SCHEDULE 13D PAGE 3 OF 10 PAGES - ----------------------- --------------------- - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON BVF Partners, L.P. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [X] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ SOURCE OF FUNDS* 4 OO - ------------------------------------------------------------------------------ CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO 5 ITEMS 2(d) or 2(e) [_] - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 6 Delaware - ------------------------------------------------------------------------------ SOLE VOTING POWER 7 NUMBER OF 0 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 8 750,367 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 9 REPORTING 0 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 10 750,367 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 11 750,367 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* 12 [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 13 5.0% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 14 PN - ------------------------------------------------------------------------------ *SEE INSTRUCTIONS BEFORE FILLING OUT! - ----------------------- --------------------- CUSIP NO. 04269 W 107 SCHEDULE 13D PAGE 4 OF 10 PAGES - ----------------------- --------------------- - ------------------------------------------------------------------------------ NAME OF REPORTING PERSON 1 S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON BVF Inc. - ------------------------------------------------------------------------------ CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* 2 (a) [X] (b) [_] - ------------------------------------------------------------------------------ SEC USE ONLY 3 - ------------------------------------------------------------------------------ SOURCE OF FUNDS* 4 WC, OO - ------------------------------------------------------------------------------ CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO 5 ITEMS 2(d) or 2(e) [_] - ------------------------------------------------------------------------------ CITIZENSHIP OR PLACE OF ORGANIZATION 6 Delaware - ------------------------------------------------------------------------------ SOLE VOTING POWER 7 NUMBER OF 0 SHARES ----------------------------------------------------------- SHARED VOTING POWER BENEFICIALLY 8 750,367 OWNED BY ----------------------------------------------------------- EACH SOLE DISPOSITIVE POWER 9 REPORTING 0 PERSON ----------------------------------------------------------- SHARED DISPOSITIVE POWER WITH 10 750,367 - ------------------------------------------------------------------------------ AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 11 750,367 - ------------------------------------------------------------------------------ CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* 12 [_] - ------------------------------------------------------------------------------ PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 13 5.0% - ------------------------------------------------------------------------------ TYPE OF REPORTING PERSON* 14 IA,CO - ------------------------------------------------------------------------------ *SEE INSTRUCTIONS BEFORE FILLING OUT! - ----------------------- --------------------- CUSIP NO. 04269 W 107 SCHEDULE 13D PAGE 5 OF 10 PAGES - ----------------------- --------------------- Amendment No. 1 (the "Amendment") to the Statement on Schedule 13D, dated October 1, 1997 (the "Statement"), filed with the Securities and Exchange Commission on behalf of Biotechnology Value Fund, L.P., a Delaware limited partnership ("BVF"), BVF Partners L.P., a Delaware limited partnership ("Partners"), and BVF Inc., a Delaware corporation ("BVF Inc." and, together with BVF and Partners, the "Reporting Persons") with respect to the Common Stock, par value $0.001 per share (the "Stock"), of Arris Pharmaceutical Corporation, a Delaware corporation ("Arris"). Item 3 is hereby amended to read in its entirety as follows: ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION. Since October 23, 1997, Partners, in its capacity as general partner of BVF, has purchased on behalf of such limited partnership an aggregate number of 42,800 shares of the Stock for an aggregate consideration of $446,383.24, utilizing funds provided by BVF from its working capital pursuant to the terms of its limited partnership agreement with Partners and has sold 138,700 shares of the Stock for an aggregate consideration of $1,494,544.39. In addition, Partners, in its capacity as investment manager with respect to certain managed accounts, has purchased on behalf of such managed accounts an aggregate number of 39,500 shares of the Stock for an aggregate consideration of $421,028.67, utilizing funds under management by Partners pursuant to investment management agreements between Partners and such managed accounts and has sold 117,000 shares of Stock for an aggregate consideration of $1,264,730.44. Item 5 is hereby amended to read in its entirety as follows: ITEM 5. INTEREST IN SECURITIES OF THE ISSUER. (a) BVF beneficially owns 398,621 shares of the Stock, Partners beneficially owns 750,367 shares of the Stock, and BVF Inc. beneficially owns 750,367 shares of the Stock, approximately 2.6%, 5.0% and 5.0%, respectively, of the aggregate number of shares outstanding as of October 31, 1997 (as reported in Arris' most recent statement on Form 10-Q). (b) BVF shares voting and dispositive power over the 398,621 shares of the Stock it beneficially owns with Partners. Partners and BVF Inc. share voting and dispositive power over the 750,367 shares of the Stock they beneficially own with, in addition to BVF, the managed accounts on whose behalf Partners, as investment manager, purchased such shares. The managed accounts on whose behalf Partners owns shares of the Stock are Investment 10 L.L.C., an Illinois limited liability company ("ILL10"), Palamundo, L.D.C., a limited duration company organized under the laws of the Cayman Islands ("Palamundo"), ZPG Securities, L.L.C., a New York limited liability company ("ZPG") and Biotechnology Value Fund, Ltd., a Cayman Islands Corporation ("BVF Ltd."). ILL10, Palamundo, ZPG and BVF - ----------------------- --------------------- CUSIP NO. 04269 W 107 SCHEDULE 13D PAGE 6 OF 10 PAGES - ----------------------- --------------------- Ltd. are collectively referred to herein as the "Accounts." The Accounts specialize in holding biotechnology stocks for investment purposes and the business address of each is BVF Partners L.P., 333 West Wacker Drive, Suite 1600, Chicago, Illinois 60606. (c) Exhibit B attached hereto contains information as to all transactions in the Stock by the Reporting Persons during the past sixty days. All such transactions were made for cash in open market, over-the-counter transactions. No other transactions in the Stock have been effected by the Reporting Persons during the past sixty days. (d) The Accounts are entitled to receive dividends and any sale proceeds with respect to the Stock in proportion to their respective ownership interests therein. (e) The Reporting Persons ceased to the beneficial owners of more than five percent of the Common Stock of Arris on December 5, 1997. Item 7 is hereby amended to read in its entirety as follows: ITEM 7. MATERIAL TO BE FILED AS EXHIBITS. Exhibit A - Agreement Regarding Joint Filing Exhibit B - Transactions in the Stock by the Reporting Persons during the last 60 days. - ----------------------- --------------------- CUSIP NO. 04269 W 107 SCHEDULE 13D PAGE 7 OF 10 PAGES - ----------------------- --------------------- After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: December 8, 1997. BIOTECHNOLOGY VALUE FUND, L.P. By: BVF Partners L.P., its general partner By: BVF Inc., its general partner By: /s/ Mark N. Lampert --------------------------------- Mark N. Lampert President BVF PARTNERS L.P. By: BVF Inc., its general partner By: /s/ Mark N. Lampert --------------------------------- Mark N. Lampert President BVF INC. By: /s/ Mark N. Lampert ------------------------------ Mark N. Lampert President EX-99.A 2 AGREEMENT REGARDING JOINT FILING EXHIBIT A AGREEMENT REGARDING JOINT FILING -------------------------------- The undersigned, Biotechnology Value Fund, L.P., a Delaware limited partnership, and BVF Partners L.P., a Delaware limited partnership, and BVF Inc., a Delaware corporation, hereby agree and acknowledge that the Amendment containing the information required by Schedule 13D, to which this Agreement is attached as an exhibit, is filed on behalf of each of them. The undersigned further agree that any further amendments or supplements thereto shall also be filed on behalf of each of them. Dated: December 8, 1997. BIOTECHNOLOGY VALUE FUND, L.P. By: BVF Partners L.P., its general partner By: BVF Inc., its general partner By: /s/ Mark N. Lampert ------------------------------ Mark N. Lampert President BVF PARTNERS L.P. By: BVF Inc., its general partner By: /s/ Mark N. Lampert ------------------------------ Mark N. Lampert President BVF INC. By: /s/ Mark N. Lampert ------------------------------- Mark N. Lampert President Page 8 of 10 Pages EX-99.B 3 TRANSACTIONS IN THE STOCK BY REPORTING PERSONS EXHIBIT B TRANSACTIONS IN THE STOCK BY THE REPORTING PERSONS -------------------------------------------------- DURING THE PAST SIXTY DAYS --------------------------
- --------------------------------------------------------------------------------------- Settlement For the Price per Date By Account of Quantity Share Type of Trade Broker - --------------------------------------------------------------------------------------- 10/23/97 Partners BVF 10,000 $12.4375 Purchase HMQT - --------------------------------------------------------------------------------------- 10/23/97 Partners BVF Ltd. 10,100 $12.4375 Purchase HMQT - --------------------------------------------------------------------------------------- 10/31/97 Partners BVF 4,000 $11.1375 Purchase PFTC - --------------------------------------------------------------------------------------- 10/31/97 Partners PAL 2,000 $11.1375 Purchase PFTC - --------------------------------------------------------------------------------------- 10/31/97 Partners BVF Ltd. 4,000 $11.1375 Purchase PFTC - --------------------------------------------------------------------------------------- 11/05/97 Partners BVF Ltd. 1,400 $11.7388 Purchase INET - --------------------------------------------------------------------------------------- 11/07/97 Partners BVF (32,300) $11.1186 Sale INET - --------------------------------------------------------------------------------------- 11/07/97 Partners ILL10 (8,000) $11.1186 Sale INET - --------------------------------------------------------------------------------------- 11/07/97 Partners PAL (4,400) $11.1186 Sale INET - --------------------------------------------------------------------------------------- 11/07/97 Partners ZPG (3,500) $11.1186 Sale INET - --------------------------------------------------------------------------------------- 11/07/97 Partners BVF Ltd. (33,000) $11.1186 Sale INET - --------------------------------------------------------------------------------------- 11/07/97 Partners BVF (20,000) $11.0625 Sale INET - --------------------------------------------------------------------------------------- 11/07/97 Partners BVF (24,000) $11.1875 Sale MIST - --------------------------------------------------------------------------------------- 11/10/97 Partners BVF (5,000) $11.5387 Sale INET - --------------------------------------------------------------------------------------- 11/10/97 Partners ILL10 (3,000) $11.5387 Sale INET - --------------------------------------------------------------------------------------- 11/10/97 Partners PAL (3,000) $11.5387 Sale INET - --------------------------------------------------------------------------------------- 11/10/97 Partners BVF Ltd. (10,000) $11.5387 Sale INET - --------------------------------------------------------------------------------------- 11/11/97 Partners BVF (16,000) $11.1875 Sale PFTC - --------------------------------------------------------------------------------------- 11/11/97 Partners ILL10 (5,000) $11.1875 Sale PFTC - --------------------------------------------------------------------------------------- 11/11/97 Partners ZPG (4,000) $11.1875 Sale PFTC - --------------------------------------------------------------------------------------- 11/11/97 Partners BVF Ltd. (8,000) $11.1875 Sale PFTC - --------------------------------------------------------------------------------------- 11/13/97 Partners BVF (10,000) $10.6532 Sale INET - --------------------------------------------------------------------------------------- 11/13/97 Partners BVF Ltd. (2,200) $10.6532 Sale INET - --------------------------------------------------------------------------------------- 11/14/97 Partners BVF (1,000) $10.4375 Sale INET - --------------------------------------------------------------------------------------- 11/14/97 Partners ILL10 (2,000) $10.7418 Sale INET - --------------------------------------------------------------------------------------- 11/14/97 Partners ZPG (2,000) $10.7418 Sale INET - ---------------------------------------------------------------------------------------
Page 9 of 10 Pages
- --------------------------------------------------------------------------------------- Settlement For the Price per Date By Account of Quantity Share Type of Trade Broker - --------------------------------------------------------------------------------------- 11/14/97 Partners BVF Ltd. (5,200) $10.7418 Sale INET - --------------------------------------------------------------------------------------- 11/17/97 Partners BVF (5,500) $ 9.6534 Sale INET - --------------------------------------------------------------------------------------- 11/18/97 Partners BVF (5,000) $ 9.5714 Sale INET - --------------------------------------------------------------------------------------- 11/18/97 Partners BVF Ltd. (2,000) $ 9.5714 Sale INET - --------------------------------------------------------------------------------------- 11/19/97 Partners BVF (7,000) $ 9.6312 Sale INET - --------------------------------------------------------------------------------------- 11/19/97 Partners BVF Ltd. (2,600) $ 9.6312 Sale INET - --------------------------------------------------------------------------------------- 11/20/97 Partners ILL10 (1,700) $ 9.7500 Sale INET - --------------------------------------------------------------------------------------- 11/21/97 Partners BVF 28,800 $ 9.5998 Purchase INET - --------------------------------------------------------------------------------------- 11/21/97 Partners ILL10 2,000 $ 9.5998 Purchase INET - --------------------------------------------------------------------------------------- 11/21/97 Partners PAL 1,000 $ 9.5998 Purchase INET - --------------------------------------------------------------------------------------- 11/21/97 Partners ZPG 2,000 $ 9.5998 Purchase INET - --------------------------------------------------------------------------------------- 11/21/97 Partners BVF Ltd. 17,000 $ 9.5998 Purchase INET - --------------------------------------------------------------------------------------- 12/04/97 Partners BVF (7,000) $10.0415 Sale PFTC - --------------------------------------------------------------------------------------- 12/04/97 Partners BVF Ltd. (3,400) $10.0415 Sale PFTC - --------------------------------------------------------------------------------------- 12/04/97 Partners BVF (1,000) $10.0000 Sale INET - --------------------------------------------------------------------------------------- 12/05/97 Partners BVF (4,900) $ 9.5000 Sale INET - --------------------------------------------------------------------------------------- 12/05/97 Partners ILL10 (2,000) $ 9.5000 Sale INET - --------------------------------------------------------------------------------------- 12/05/97 Partners PAL (2,000) $ 9.5000 Sale INET - --------------------------------------------------------------------------------------- 12/05/97 Partners ZPG (2,000) $ 9.5000 Sale INET - --------------------------------------------------------------------------------------- 12/05/97 Partners BVF Ltd. (8,000) $ 9.5000 Sale INET - ---------------------------------------------------------------------------------------
HMQT = Hambrecht, Quist INET = Instinet PFTC = Preferred Technologies MIST = Mr. Stock Page 10 of 10 Pages -----END PRIVACY-ENHANCED MESSAGE-----